Marjolein Kikkert

Title: Marjolein Kikkert: Innovator in Arterivirus Research

Introduction

Marjolein Kikkert is a prominent inventor based in Sassenheim, Netherlands. She has made significant contributions to the field of virology, particularly in the study of arteriviruses. Her innovative work has led to advancements in medical applications, including vaccines and therapeutics.

Latest Patents

Marjolein Kikkert holds a patent for "Live attenuated replication-competent arteriviruses having decreased DUB/deISGylating activity." This invention relates to replication-competent arteriviruses that exhibit a decreased DUB/deISGylating activity due to a mutation in the PLP2 domain of the non-structural protein nsp2. The patent outlines their use as a medicament, their application in vaccines, and the formation of Arteriviral PLP2-ubiquitin complexes.

Career Highlights

Kikkert's career is marked by her dedication to research and innovation in virology. She is affiliated with the University of Manitoba, where she continues to explore the potential of her inventions in combating viral diseases. Her work has garnered attention for its implications in vaccine development and disease prevention.

Collaborations

Marjolein Kikkert has collaborated with notable colleagues, including Puck Bertyne Van Kasteren and Terrence William James. These partnerships have enhanced her research efforts and contributed to the advancement of knowledge in her field.

Conclusion

Marjolein Kikkert's contributions to the field of virology through her innovative patents and collaborative efforts highlight her role as a leading inventor. Her work continues to pave the way for advancements in medical science and public health.